Mylan Pharmaceuticals Inc recalls Prasugrel Tablets
- Published
- 9 Sept 2026
- Units affected
- 47,662 bottles
- Agency
- FDA
- Country
- United States
The hazard
Failed Dissolution Specifications; product failed to meet 18-month stability testing acceptance criteria
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Prasugrel Tablets, USP, 10mg, Rx only, 30 Tablets in each bottle, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV 26505, Made in India, NDC 0378-5186-93.
- Brand / company
- Mylan Pharmaceuticals Inc
- Codes / lots
- Lot #: 3225272, Exp. September 30, 2026
- Distribution
- Nationwide within the U.S
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 9 Sept 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.